The FGA Thr312Ala polymorphism and risk of intracerebral haemorrhage in Polish and Greek populations by Jagiełła, Jeremiasz et al.
Original research article
The FGA Thr312Ala polymorphism and risk of intracerebral
haemorrhage in Polish and Greek populations
Jeremiasz Jagiełła a,*, Efthimios Dardiotis b, Jerzy Gąsowski c, Joanna Pera d,
Tomasz Dziedzic d, Aleksandra Klimkowicz-Mrowiec d, Aleksandra Golenia d,
Marcin Wnuk d, Kostas Fountas e, Konstantinos Paterakis b,
Georgios Hadjigeorgiou b, Agnieszka Słowik d
aDepartment of Neurology, The University Hospital in Krakow, Krakow, Poland
bDepartment of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece
cChair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland
dDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland
eDepartment of Neurosurgery, University of Thessaly, University Hospital of Larissa, Larissa, Greece
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 1 0 5 – 1 1 0
a r t i c l e i n f o
Article history:
Received 24 April 2013
Accepted 6 December 2013
Available online 23 January 2014
Keywords:
Intracerebral haemorrhage
Brain haemorrhage
Haemorrhagic stroke
FGA Thr312Ala
a b s t r a c t
Background and purpose: Spontaneous intracerebral haemorrhage (ICH) is the most fatal form
of stroke with the highest morbidity and disability rate of all stroke types. Recent data
suggest that the genetic background has a sizeable and mostly undiscovered effect on the
brain haemorrhage risk. Since the coagulation system is crucial to ICH pathology, we studied
the signiﬁcance of the FGA Thr312Ala polymorphism in two European populations.
Materials and methods: We genotyped 550 and 224 controls as well as 261 and 242 stroke
patients in Polish and Greek populations, respectively. The ICH diagnosis was conﬁrmed by
computed tomography. The FGA Thr312Ala polymorphism was analysed using real-time
polymorphism chain reaction.
Results: Both crude and multivariable regression analyses showed that the studied poly-
morphism is a protective factor in the Polish population under the dominant and additive
models of inheritance. Those results did not replicate in the Greek population. The meta-
analysis of results from the Polish and the Greek populations proved that FGA Thr312Ala
polymorphism affects the risk of ICH in the dominant model of inheritance.
Conclusions: The FGA Thr312Ala polymorphism affects a risk for ICH in the Polish but not in
the Greek population. An advanced meta-analysis of well-designed studies with a signiﬁ-
cant number of cases might provide useful information of novel polymorphisms, including
the FGA Thr312Ala polymorphism, and their role in ICH pathology.
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Spontaneous intracerebral haemorrhage (ICH) is the most fatal
form of stroke with the highest morbidity and disability rate of
all stroke types [1]. Its prevalence is growing since the
populations of developed countries are ageing and antic-
oagulation treatment is becoming more common in the elderly
population [2,3]. Despite many clinical trials, no speciﬁc
pharmacological or surgical treatment is available. In such
circumstances, understanding the pathology of brain hae-
morrhage is crucial [4].
Intracerebral haemorrhage is caused by a rupture of a small
vessel damaged either by chronic hypertension (it is more
common in the deep brain structures, and hence is referred to
as deep or non-lobar haemorrhage) or amyloid angiopathy
(occurs usually at the border of white and grey matter, and
thus is referred to as lobar haemorrhage) [5].
The most recent view on brain haemorrhage takes it to be
an acute manifestation of a chronic and progressive vascular
disease [6,7]. The prevalence of cerebral microbleeds (CMBs)
has been found to be associated with ICH [8], as well to be a
predictor of ICH [9]. Thus, haemorrhagic stroke is assumed to
be a clinical manifestation of the evolution of one of many
microbleeds to an extended haematoma. The process depends
on the size and type of vascular damage, local inﬂammation
response, as well as the properties and characteristics of the
coagulation system.
Apart from the well-established ICH risk factors, epidemi-
ological data suggest that the genetic background has a
sizeable and mostly undiscovered effect on the brain hae-
morrhage risk [4]. Since the main goal of the haemostatic
system is to maintain the balance between bleeding and
coagulation, the genetic mutations of coagulation factors that
alter its functioning are natural candidates for the ICH risk
factors.
The FGA Thr312Ala (A > G) polymorphism occurs in the
region of ﬁbrinogen, which is crucial to factor XIII-induced
cross-linking of ﬁbrin ﬁbres and causes amino-acid substi-
tution. The clot forming process includes a series of FXIII-
dependent protein cleavages and new chemical bonds
generation. The amino-acid substitution changes the struc-
ture of a mature protein and lowers its afﬁnity for degrading
enzymes, which consequently leads to increased clot's
resistance to thrombolysis and risk of intravascular emboli-
sation [10]. Hence the FGA Thr312Ala polymorphism
has been proved a risk factor for venous thromboembolism
[11] and chronic thromboembolic pulmonary hypertension
[12].
Moreover, we previously showed that ﬁbrin clot proper-
ties play a signiﬁcant role in the acute phase of ICH [13].
Since in ICH, in contrast to intravascular coagulation in
the above-mentioned conditions, uncontrolled bleeding is
a major pathology, we hypothesize that the analyzed
polymorphism might have a protective effect on brain
haemorrhage.
The aim of that paper is to analyze the correlation between
the ICH prevalence and the polymorphism of the ﬁbrinogen
alpha chain gene FGA Thr312Ala. As it is widely acknowledged
that genetic case-control studies should be replicated inethnically different populations, we decided do compare the
results obtained from the Polish population with those
received from the Greek population. Many studies have shown
that there are major differences in the genetic structure of the
southern (e.g. Greek, Spanish, Italian) European populations
and those with northern European ancestry (including the
Polish populations) [14,15].
2. Materials and methods
Two hundred and sixty-one patients presenting with haemor-
rhagic stroke, admitted to the Stroke Unit, Department of
Neurology, University Hospital in Krakow, Poland, between
1999 and 2009 were enrolled into the study. The control group
consisted of 550 individuals without stroke, matched for sex
and age. All the patients and controls were Caucasians and of
Polish origin.
Moreover, 242 patients with haemorrhagic stroke treated in
the General University Hospital of Larissa and 224 healthy
controls recruited from the Greek populations living in the
area of Larissa in the Central Greece, matched for sex and age
were analyzed and genotyped to replicate the study results
[16].
The ICH diagnosis was conﬁrmed by computed tomogra-
phy (CT). Computed tomography angiography or magnetic
resonance imaging was used for identifying or excluding
secondary causes of haemorrhage, including arteriovenous
malformations, tumours, and cerebral vein thrombosis.
Standardised questionnaire on demographics, medical
history and vascular risk factors, including hypertension,
ischaemic heart disease, myocardial infarction, atrial ﬁbrilla-
tion, hypercholesterolaemia, diabetes mellitus, alcohol intake
and smoking was completed by each of the participants, both
from the Polish and from the Greek populations.
The healthy controls were recruited from the hospital
staff families, consecutive spouses of the patients, or were
volunteers from the community. They had no medical
history of neurological disorders and were matched accord-
ing to the International Stroke Genetic Consortium (ISGC)
criteria [17]. All the subjects, both in the Polish and Greek
cohorts, gave an informed consent. The study project was
approved by the Jagiellonian University Medical College and
the University Hospital ethics committee in Poland and by
the Univeristy Research Committee of the University of
Larissa.
Genomic DNA was extracted from peripheral blood using a
commercially available kit from QIAGEN® (QIAmp, Blood Mini
Kit). The FGA Thr312Ala polymorphism was determined by the
real time polymerase chain reaction (RT PCR) using TaqMan
7900 device (by Applied Biosystems, Carlsbad, California). The
genotyping results were analyzed using Applied Biosytems
software (Sequence Detection System, SDS). In ambiguous
cases, we veriﬁed the results by the standard polymerase
chain reaction (PCR) with enzymatic digestion and subsequent
gel electrophoresis.
To perform a genetic analysis, we used 'Statistica' and 'SAS
Genetics' software. To conduct a meta-analysis of the two
studied populations, we applied the two-value binary logic
model optimised by the Newton–Raphson method. The
Table 1 – The demographic characteristics and vascular risk factors profile in patients with intracerebral haemorrhage (ICH) and control group in Polish and Greek
populations (model 1 – crude analysis of risk factors and risk of ICH; model 2 – analysis of risk factors and risk of ICH after adjustment for age and sex).
ICH patients Controls OR (95% CI) ( p)a OR (95% CI) (p)b
Polish
population
Greek
population
Polish
population
Greek
population
Polish
population
Greek
population
Polish
population
Greek
population
Age 65.0 (13.9) 64.1 (13.0) 57.1 (17.1) 64.2 (12.8) 1.03 (1.02–1.04) (<0.01) 1.0
1.0–1.0 (0.94)
1.03
1.02–1.04 (<0.01)
1.0
1.0–1.0 (0.93)
Gender (male) 141 (51.6%) 159 (63.6%) 340 (44.9%) 163 (65.2%) 1.3
1.0–1.7 (0.05)
0.9
0.6–1.3 (0.71)
1.5
1.1–2.0 (<0.01)
0.9
0.6–1.3 (0.71)
Hyper-tension 216 (80.6%) 199 (79.6%) 297 (39.7%) 113 (45.2%) 6.3
4.5–8.8 (<0.01)
4.7
3.2–7.0 (<0.01)
5.3
3.7–7.5 (<0.01)
5.7
3.7–8.7 (<0.01)
Ischaemic heart disease 82 (30.7%) 31 (12.4%) 165 (22.1%) 32 (12.8%) 1.6
1.1–2.1 (<0.01)
1.0
0.6–1.6 (0.89)
1.0
0.7–1.4 (0.99)
1.0
0.6–1.7 (0.88)
Diabetes 48 (18.3%) 32 (12.8%) 72 (9.6%) 35 (14.0%) 2.1
1.4–3.1 (<0.01)
0.9
0.5–1.5 (0.69)
1.6
1.1–2.4 (0.02)
0.9
0.5–1.5 (0.712)
Smoking 67 (28.2%) 58 (23.3%) 178 (23.8%) 37 (14.8%) 1.3
0.9–1.7 (0.18)
1.7
1.1–2.7 (0.02)
1.5
1.0–2.1 (0.03)
1.8
1.1–2.8 (0.02)
Alcohol 19 (7.9%) 72 (28.8%) 70 (9.4%) 62 (24.8%) 0.8
(0.5–1.4) (0.50)
1.2
0.8–1.8 (0.31)
0.9
(0.5–1.6) (0.69)
1.2
0.8–1.9 (0.28)
Hyper-cholesterolaemia 101 (39.0%) 83 (33.2%) 203 (29.9%) 77 (30.8%) 1.5
(1.1–2.0) (0.01)
1.1
0.8–1.6 (0.57)
1.2
(0.9–1.7) (0.18)
1.1
0.8–1.6 (0.56)
OR, odds ratio; CI, conﬁdence interval.
a x2-test – one degree of freedom, Table 2  2.
b Logistic analysis after adjustment for sex and age.
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Table 2 – FGA Thr312Ala (A > G) (rs6050) polymorphism at the 4 chromosome and intracerebral haemorrhage (ICH) risk in Polish and Greek populations.
ICH (lobar and deep) ICH (deep)
N (%) N (%) OR (95% CI) (p) OR (95% CI) (p) N (%) N (%) OR (95% CI) ( p) OR (95% CI) (p)
Polish population
Genotypes
AA 167 (64.0%) 326 (59.3%) 2.9 (1.2–7.0) (0.01)a 6.9 (1.5–30.9) (0.01)b 102 (65.4%) 326 (59.2%) 2.1 (0.8–5.3) (0.13)a 3.0 (0.9–10.4) (0.09)b
AG 88 (33.7%) 189 (34.4%) 1.2 (0.9–1.7) (0.20)c 1.4 (1.0–2.1) (0.07)d 49 (31.4%) 189 (34.4%) 1.3 (0.9–1.9) (0.17)c 1.4 (1.0–2.2) (0.08)d
GG 6 (2.3%) 35 (6.4%) 0.8 (0.6–1.0) (0.05)e 0.7 (0.5–0.9) (0.01)f 5 (3.2%) 35 (6.4%) 0.8 (0.6–1.0) (0.09)e 0.7 (0.5–1.0) (0.04)f
Allele
A 422 (80.8%) 841 (76.5%) 0.8 (0.6–1.0) (0.05)z 0.7 (0.5–0.9) (0.01)zz 253 (81.1%) 841 (76.5%) 0.8 (0.6–1.0) (0.08)z 0.7 (0.5–1.0) (0.04)zz
G 100 (19.2%) 259 (23.5%) 59 (18.9%) 259 (23.5%)
Greek population
Genotypes
AA 142 (58.7%) 145 (64.7%) 1.2 (0.5–2.8) (0.69)a 1.4 (0.6–3.5) (0.46)b 96 (59.6%) 145 (64.7%) 1.1 (0.4–2.7) (0.87)a 1.5 (0.5–4.0) (0.46)b
AG 89 (36.8%) 67 (29.9%) 0.8 (0.5–1.1) (0.18)c 0.8 (0.5–1.2) (0.28)d 57 (35.4%) 67 (29.9%) 0.8 (0.5–1.2) (0.31)c 0.9 (0.6–1.4) (0.60)d
GG 11 (4.5%) 12 (5.4%) 1.2 (0.9–1.6) (0.34)e 1.1 (0.8–1.6) (0.54)f 8 (5.0%) 12 (5.4%) 1.1 (0.8–1.6) (0.44)e 1.0 (0.7–1.5) (0.88)f
Allele
A 373 (77.1%) 357 (79.7%) 1.2 (0.9–1.6) (0.33)z 1.1 (0.8–1.6) (0.54)zz 249 (77.3%) 357 (79.7%) 1.2 (0.8–1.6) (0.43)z 1.0 (0.7–1.5) (0.88)zz
G 111 (22.9%) 91 (20.3%) 73 (22.7%) 91 (20.3%)
OR, odds ratio; CI, conﬁdence interval.
a x2 test (one degree of freedom, Table 2  2), performed for dominant effect of A allele (AA + AG vs. GG) in both analyzed groups (patients presented with ICH and control group).
b Logistic regression model testing dominant effect of A allele (AA + AG vs. GG) on ICH risk after adjustment for sex, age and vascular risk factors (hypertension, diabetes, smoking,
hypercholesterolaemia) (patients presented with ICH and control group).
c x2 test (one degree of freedom, Table 2  2), performed for recessive effect of A allele (AA vs. AG + GG) in both analyzed groups (patients presented with ICH and control group).
d Logistic regression model testing recessive affect of A allele (AA vs. AG + GG) on the ICH risk after adjustment for sex, age and vascular risk factors (hypertension, diabetes, smoking,
hypercholesterolaemia) (patients presented with ICH and control group).
e Additive model applied by trend test (Cochran–Armitage trend test) in both analyzed groups (patients presented with ICH and control group).
f Logistic regression model testing additive affect (AA vs. AG vs. GG) on ICH risk after adjustment for sex, age and vascular risk factors (hypertension, diabetes, smoking, hypercholesterolaemia)
(patients presented with ICH and control group).
z x2 test (one degree of freedom, Table 2  2), performed on A and G alleles in both analyzed groups (patients presented with ICH and control group).
zz x2 test (one degree of freedom, Table 2  2), performed on A and G alleles in both analyzed groups (patients presented with ICH and control group) after adjustment for sex and age.
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n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 1 0 5 – 1 1 0 109analysis of the studied groups was performed using x2-test or
Student's t-test. The Hardy–Weinberg equilibrium was tested
by x2-test. The association of the FGA Thr312Ala polymor-
phism with ICH was tested using the multivariable logistic
regression under dominant (AA + AG vs. GG), recessive (AA vs.
AG + GG) or additive (AA vs. AG vs. GG) models of inheritance.
A p-value less than 0.05 was considered as signiﬁcant.
3. Results
We genotyped 261 patients with haemorrhagic stroke and 550
controls from the Polish population as well as 242 patients and
224 controls from the Greek population. There was no
deviation from the Hardy–Weinberg equilibrium regarding
the FGA Thr312Ala polymorphism in each of the studied
groups ( p > 0.05). The demographic characteristics and vas-
cular risk factors proﬁle for the Polish and Greek populations
are summarised in Table 1.
Out of 261 patients who were successfully genotyped in the
Polish population, 60% (n = 156) presented with deep haemor-
rhage and 39% (n = 102) with lobar haemorrhage. Likewise, in
the Greek population 67% (n = 161) of the patients manifested
deep haemorrhage and 33% (n = 81) lobar haemorrhage. The
alleles and genotypes distribution was signiﬁcantly different
between the patients with ICH and controls in the Polish
population (patients: AA – 64.0% (n = 167), AG – 33.7% (n = 88),
GG – 2.3% (n = 6), A – 80.8% (n = 422); controls: AA – 59.3%
(n = 326), AG – 34.4% (n = 189), GG – 6.4% (n = 35); A – 76.5%
(n = 841); x2 test, p < 0.05) but not in the Greek population
(patients: AA – 58.7% (n = 142), AG – 36.8% (n = 89), GG – 4.5%
(n = 11), A – 77.1% (n = 373); controls: AA – 64.7% (n = 145), AG –
29.9% (n = 67), GG – 5.4% (n = 12); A – 79.7% (n = 357); x2 test,
p > 0.05) (Table 2). Similarly, we found a signiﬁcant difference
in the alleles but not in the genotypes distribution in patients
with deep haemorrhage in the studied Polish population
(Table 2).
Moreover, the multivariable logistic regression analysis,
both crude and adjusted for vascular risk factors, showed the
signiﬁcance of the FGA Thr312Ala polymorphism as a
protective factor for haemorrhagic stroke, under the dominant
and additive models of inheritance (Table 2).
Those results did not replicate in the Greek population. The
analysis of the combined results proved the effect of the
analyzed polymorphism on ICH in the dominant model of
inheritance (Table 3).Table 3 – The combined analysis of FGA Thr312Ala (A > G) (rs6
Polymorphism 
po
OR (
FGA Thr312Ala (A > G) (dominant model, adjusted for age,
sex, hypertension and smoking)
6.
(0.
FGA Thr312Ala (A > G) (additive model,
adjusted for age, sex, hypertension and smoking)
0.
(0.
OR, odds ratio; CI, conﬁdence interval.
a Two-value binary logic model optimised by the Newton–Raphson meth4. Discussion
We found that the FGA Thr312Ala is associated with ICH in the
Polish but not in the Greek population. Multivariable logistic
regression adjusted for vascular risk factors revealed that the
AA (Ala) genotype of the studied polymorphism has a higher
prevalence in the Polish population of patients with brain
haemorrhage under the dominant and additive model of
inheritance. In the group of patients with deep haemorrhage in
the Polish population, the A allele was signiﬁcantly more
frequent than in the control population. The analysis of the
combined data showed that the AA genotype is signiﬁcantly
correlated with a higher prevalence of ICH in the two analyzed
populations.
No literature analysing the FGA Thr312Ala polymorphism
as a risk factor for ICH has been published so far.
As we mentioned in the introduction, we assumed that
genetic variations that inﬂuence the clotting process and
therefore alter the enlargement of small brain microbleeds
might be a proper candidate for investigation of novel ICH-
related genes.
Moreover, we showed in the previous publication that in
acute ICH, some properties of ﬁbrin clot are changed, e.g. the
time of clot lysis, which supports the hypothesis that
coagulation and clotting are crucial to the process of small
bleeding evolving to haematoma [13]. Other factors (clot
compaction, maximum rate of D-dimer release in the lysis
assay) correlate with the haematoma volume or neurological
deﬁcit examined by the National Institutes of Health Stroke
Scale (NIHSS).
A question might be posed if we should analyze the
association of the studied polymorphism and ICH prevalence
or whether we should try to ﬁnd a correlation with the clinical
markers of ICH progress such as the haematoma volume
change in time, or clinical assessment.
Another problem is that the obtained results do not
replicate in the Greek population. We did not conﬁrm any
trends in the Greek group of patients with ICH. The reason
might be a small and inadequate number of the analyzed cases
and controls, which suggests a need for a study with a higher
power. What is more, substantial differences in the demogra-
phy of the patient and control groups were observed in the
Polish population (Table 1). This might be one of the reasons
why the results in the Greek cohort did not replicate. Besides,
in the previous co-authored publication, we did not conﬁrm050) polymorphism in Polish and Greek population.
Polish
pulation
95% CI) ( p)
Greek
population
OR (95% CI) ( p)
Analysis of
combined resultsa
OR (95% CI) ( p)
8 (1.5–30.0) 1.4 (0.6–3.5) 2.3 (1.1–4.8)
01) (0.46) (0.03)
7 (0.5–0.9) 1.1 (0.8–1.5) 0.9 (0.7–1.1)
01) (0.57) (0.36)
od.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 1 0 5 – 1 1 0110the common mechanisms of haemorrhagic stroke pathology
in those two populations [18]. It might suggest that the genetic
background of ICH varies within the speciﬁc European
subpopulations.
Thorough understanding of coagulation process seems to
be the most recent and promising method for speciﬁc ICH
prevention. Anticoagulant therapy, adjusted to the genetic
proﬁle, might signiﬁcantly reduce the ratio of undesirable
complications, including ICH. Henceforth, novel ICH-related
genes identiﬁcation is crucial to ﬁnding new ICH prevention
strategies.
5. Conclusions
1. The FGA Thr312Ala polymorphism affects a risk for ICH in
the Polish but not in the Greek population.
2. An advanced meta-analysis of well-designed studies with a
signiﬁcant number of cases might provide useful informa-
tion of novel polymorphisms, including the FGA Thr312Ala
polymorphism, and their role in ICH pathology.
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